Skip to main content
Quest Diagnostics

Low Performance of Hepatitis Delta Virus Testing Among Two National Cohorts of Chronic Hepatitis B Patients in the United States

Low performance of hepatitis delta virus testing among two national cohorts of chronic hepatitis B patients in the United States

Authors: Wong RJ, Kaufman HW, Niles JK, Chen C, Yang Z, Kapoor H, Cheung R, Gish RG.

Citation: Am J Gastroenterol. 2022 Dec 1;117(12):2067-2070. doi: 10.14309/ajg.0000000000001947

Specialties: Infectious Disease

Download key summary

Related content

Conference Presentation
Very low rates of hepatitis delta virus testing among a large national cohort of patients with chronic hepatitis B infection
Publication
Simplifying Treatment Criteria in Chronic Hepatitis B: Reducing Barriers to Elimination
Publication
Prevalence of Hepatitis B Virus and Latent Tuberculosis CoInfection in the United States

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2025 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.